Patents by Inventor Christopher Andrew Bunka

Christopher Andrew Bunka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250177489
    Abstract: Disclosed herein are compositions and methods for treating diabetes wherein the compositions comprise GLP-1 agonists. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels. Disclosed herein are methods for treating type-2 diabetes in a subject, for lowering a subject's A1C, for lowering the body mass of a subject, and for regulating the incretin hormone levels of a subject.
    Type: Application
    Filed: December 3, 2024
    Publication date: June 5, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • Publication number: 20250177488
    Abstract: Disclosed herein are compositions and methods for treating diabetes wherein the compositions comprise GLP-1 agonists. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels. Disclosed herein are methods for treating type-2 diabetes in a subject, for lowering a subject's A1C, for lowering the body mass of a subject, and for regulating the incretin hormone levels of a subject.
    Type: Application
    Filed: December 3, 2024
    Publication date: June 5, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • Publication number: 20250177314
    Abstract: Disclosed herein are compositions and methods for treating diabetes wherein the compositions comprise GLP-1 agonists. The disclosed compositions are also effective for reducing body weight and improving triglyceride and cholesterol levels. Disclosed herein are methods for treating type-2 diabetes in a subject, for lowering a subject's A1C, for lowering the body mass of a subject, and for regulating the incretin hormone levels of a subject.
    Type: Application
    Filed: December 3, 2024
    Publication date: June 5, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • Patent number: 12220422
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: February 14, 2024
    Date of Patent: February 11, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • Patent number: 12213986
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: January 19, 2024
    Date of Patent: February 4, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • Publication number: 20250032518
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Application
    Filed: February 14, 2024
    Publication date: January 30, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • Publication number: 20250032517
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Application
    Filed: January 19, 2024
    Publication date: January 30, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • Publication number: 20250032516
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Application
    Filed: July 24, 2023
    Publication date: January 30, 2025
    Inventors: John Docherty, Christopher Andrew Bunka
  • Publication number: 20240226033
    Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
    Type: Application
    Filed: March 25, 2024
    Publication date: July 11, 2024
    Inventors: John Docherty, Christopher Andrew Bunka
  • Patent number: 12023346
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: July 2, 2024
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka
  • Patent number: 11986485
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: May 21, 2024
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka
  • Patent number: 11980593
    Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
    Type: Grant
    Filed: July 5, 2022
    Date of Patent: May 14, 2024
    Assignee: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • Patent number: 11944635
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: April 2, 2024
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka
  • Patent number: 11931369
    Abstract: Disclosed herein are compositions and methods for delivering compositions to a subject in need of treatment for epilepsy. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering cannabidiol and CBD-containing compositions to subjects in need of treatment for epilepsy.
    Type: Grant
    Filed: July 24, 2023
    Date of Patent: March 19, 2024
    Assignee: POVIVA CORP
    Inventors: John Docherty, Christopher Andrew Bunka
  • Publication number: 20240009141
    Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
    Type: Application
    Filed: July 5, 2022
    Publication date: January 11, 2024
    Inventors: John Docherty, Christopher Andrew Bunka
  • Publication number: 20240009140
    Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
    Type: Application
    Filed: July 5, 2022
    Publication date: January 11, 2024
    Inventors: John Docherty, Christopher Andrew Bunka
  • Publication number: 20230301341
    Abstract: Disclosed herein are compositions and methods for oral delivery of nicotine and nicotine derivatives. In one embodiment the nicotine is delivered in an oral packets, pouches, or sachets.
    Type: Application
    Filed: March 22, 2022
    Publication date: September 28, 2023
    Applicant: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • Patent number: 11700875
    Abstract: Disclosed herein are compositions and methods for oral delivery of nicotine and nicotine derivatives. In one embodiment the nicotine is delivered in an oral packets, pouches, or sachets.
    Type: Grant
    Filed: March 22, 2022
    Date of Patent: July 18, 2023
    Assignee: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • Patent number: 11666544
    Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
    Type: Grant
    Filed: July 5, 2022
    Date of Patent: June 6, 2023
    Assignee: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka
  • Patent number: 11666543
    Abstract: Disclosed herein are compositions and methods for delivering cannabidiol to subject in need of hypertension treatment. The disclosed compositions are orally delivered. Further disclosed are kits comprising the disclosed compositions as part of a method of delivering the cannabidiol-containing compositions.
    Type: Grant
    Filed: July 5, 2022
    Date of Patent: June 6, 2023
    Assignee: POVIVA CORP.
    Inventors: John Docherty, Christopher Andrew Bunka